Breast Cancer — Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment
Citation(s)
Ahles TA, Saykin A Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Invest. 2001;19(8):812-20. Review.
Bender CM, Paraska KK, Sereika SM, Ryan CM, Berga SL Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: a critical review. J Pain Symptom Manage. 2001 May;21(5):407-24. Review.
Cimprich B, So H, Ronis DL, Trask C Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psychooncology. 2005 Jan;14(1):70-8.
Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn. 2005 Oct;59(1):60-70. Epub 2005 Jun 21. Review.
Jansen CE, Miaskowski C, Dodd M, Dowling G Chemotherapy-induced cognitive impairment in women with breast cancer: a critique of the literature. Oncol Nurs Forum. 2005 Mar 5;32(2):329-42. Review.
Morse R, Rodgers J, Verrill M, Kendell K Neuropsychological functioning following systemic treatment in women treated for breast cancer: a review. Eur J Cancer. 2003 Nov;39(16):2288-97. Review.
O'Shaughnessy J Chemotherapy-related cognitive dysfunction in breast cancer. Semin Oncol Nurs. 2003 Nov;19(4 Suppl 2):17-24. Review.
Paraska K, Bender CM Cognitive dysfunction following adjuvant chemotherapy for breast cancer: two case studies. Oncol Nurs Forum. 2003 May-Jun;30(3):473-8.
Phillips KA, Bernhard J Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. J Natl Cancer Inst. 2003 Feb 5;95(3):190-7. Review.
Shilling V, Jenkins V Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs. 2007 Feb;11(1):6-15. Epub 2006 Jul 17.
Tannock IF, Ahles TA, Ganz PA, Van Dam FS Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol. 2004 Jun 1;22(11):2233-9. Review.
Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004 Jun 1;100(11):2292-9.
Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment, A Pilot Study
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
